Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Wolfe

Showing results (181-190 of 192) with videos related to

Pageof 20
Sort By:
Vaccines|August 26, 2022
The Evolution of Medical Countermeasures for Ebola Virus Disease: Lessons Learned and Next StepsIan Crozier, Kyla A Britson, Daniel N Wolfe, et al.
Bioorganic & Medicinal Chemistry Letters|August 28, 2007
Structure-activity relationship studies of carboxamido-biaryl ethers as opioid receptor antagonists (OpRAs). Part 1Kumiko Takeuchi, William G Holloway, Jamie H McKinzie, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|July 1, 1996
Intraoperative heparinisation, blood loss and myocardial infarction during aortic aneurysm surgery: a Joint Vascular Research Group studyJ F Thompson, M A Mullee, P R Bell, et al.
Viruses|October 27, 2022
Natural History of Marburg Virus Infection to Support Medical Countermeasure DevelopmentJason E Comer, Trevor Brasel, Shane Massey, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 28, 2024
Development of Next-Generation COVID-19 Vaccines: Biomedical Advanced Research and Development Authority (BARDA-)-Supported Phase 2b Study DesignsDaniel N Wolfe, Elizabeth Arangies, Gloria L David, et al.
Vaccines|June 24, 2022
Natural History of <i>Sudan ebolavirus</i> to Support Medical Countermeasure DevelopmentCaroline Carbonnelle, Marie Moroso, Delphine Pannetier, et al.
NPJ Vaccines|April 12, 2023
Mucosal vaccines for SARS-CoV-2: scientific gaps and opportunities-workshop reportJane M Knisely, Lucas E Buyon, Rebecca Mandt, et al.
Bioorganic & Medicinal Chemistry Letters|February 25, 2006
N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptakeJ R Boot, S L Boulet, B P Clark, et al.
Health Security|January 30, 2025
A Framework for Assessing Viral Pathogens: A Key Element of the BARDA Emerging Infectious Diseases StrategyRichard C White, Gerald Kovacs, Suchismita Chandran, et al.
Nature Communications|November 12, 2024
Neutralizing antibody correlate of protection against severe-critical COVID-19 in the ENSEMBLE single-dose Ad26.COV2.S vaccine efficacy trialLindsay N Carpp, Ollivier Hyrien, Youyi Fong, et al.
Pageof 20

Showing results (181-190 of 192) with videos related to

Sort By:
Pageof 20
Vaccines|August 26, 2022
The Evolution of Medical Countermeasures for Ebola Virus Disease: Lessons Learned and Next StepsIan Crozier, Kyla A Britson, Daniel N Wolfe, et al.
Bioorganic & Medicinal Chemistry Letters|August 28, 2007
Structure-activity relationship studies of carboxamido-biaryl ethers as opioid receptor antagonists (OpRAs). Part 1Kumiko Takeuchi, William G Holloway, Jamie H McKinzie, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|July 1, 1996
Intraoperative heparinisation, blood loss and myocardial infarction during aortic aneurysm surgery: a Joint Vascular Research Group studyJ F Thompson, M A Mullee, P R Bell, et al.
Viruses|October 27, 2022
Natural History of Marburg Virus Infection to Support Medical Countermeasure DevelopmentJason E Comer, Trevor Brasel, Shane Massey, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 28, 2024
Development of Next-Generation COVID-19 Vaccines: Biomedical Advanced Research and Development Authority (BARDA-)-Supported Phase 2b Study DesignsDaniel N Wolfe, Elizabeth Arangies, Gloria L David, et al.
Vaccines|June 24, 2022
Natural History of <i>Sudan ebolavirus</i> to Support Medical Countermeasure DevelopmentCaroline Carbonnelle, Marie Moroso, Delphine Pannetier, et al.
NPJ Vaccines|April 12, 2023
Mucosal vaccines for SARS-CoV-2: scientific gaps and opportunities-workshop reportJane M Knisely, Lucas E Buyon, Rebecca Mandt, et al.
Bioorganic & Medicinal Chemistry Letters|February 25, 2006
N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptakeJ R Boot, S L Boulet, B P Clark, et al.
Health Security|January 30, 2025
A Framework for Assessing Viral Pathogens: A Key Element of the BARDA Emerging Infectious Diseases StrategyRichard C White, Gerald Kovacs, Suchismita Chandran, et al.
Nature Communications|November 12, 2024
Neutralizing antibody correlate of protection against severe-critical COVID-19 in the ENSEMBLE single-dose Ad26.COV2.S vaccine efficacy trialLindsay N Carpp, Ollivier Hyrien, Youyi Fong, et al.
Pageof 20